CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced ...
Source: Esperion Therapeutics, Inc. 2024 GlobeNewswire, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results